8-K

                  LOGO


          N E W S   R E L E A S E


For Immediate Release

Contact: HemaCare Corporation
	 JoAnn Stover, Director of Investor Relations
         877.310.0717
         www.hemacare.com


   HEMACARE REOPENS CHIEF FINANCIAL OFFICER SEARCH
- ------------------------------------------------------
  Los Angeles, CA, July 8, 2003 - HemaCare Corporation (OTC
Bulletin Board: HEMA) announced today that it has reopened its
search for a Chief Financial Officer. Rose Marcario, who had
accepted the position late last month, was unable to assume the
role due to personal reasons.

 "Although we are disappointed, we are fortunate to have
interviewed several very talented candidates and expect to fill
the position in the near future," stated Judi Irving, HemaCare's
President and Chief Executive Officer.
The Company has engaged an outside financial consultant to
assist during the transition period.


                  ABOUT HEMACARE CORPORATION
  Founded in 1978, HemaCare is a national provider of blood
products and services and the only publicly traded company engaged in
the blood services industry in the U.S.  HemaCare is licensed by the
FDA and accredited by the American Association of Blood Banks.  The
company focuses on providing cost effective, high quality solutions to
the blood-related needs of U.S. hospitals.

This press release may contain "forward-looking statements" within the
meaning of the term in the Private Securities Litigation Reform Act of
1995 (Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended).  Additional
written or oral forward-looking statements may be made by the Company
from time to time in filings with the Securities and Exchange Commission
or otherwise.  Statements contained herein that are not historical facts
are forward-looking statements pursuant to the safe harbor provisions
referenced above.  Forward-looking statements are inherently subject to
risks and uncertainties some of which cannot be predicted or quantified.
Such risks and uncertainties include, without limitation, the risks and
uncertainties set forth from time to time in reports filed by the Company
with the Securities and Exchange Commission.  Although the Company believes
that the expectations reflected in such forward-looking statements are
reasonable, it can give no assurance that such expectations will prove
to be correct.  Consequently, future events and actual results could
differ materially from those set forth in, or contemplated by, the
forward-looking statements contained herein.  The Company undertakes no
obligation to publicly release any revision to these forward-looking
statements made to reflect events or circumstances after the date hereof.

EX-99

                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D. C. 20549



                            FORM 8-K

                         CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
                              1934



Date of Report (Date of earliest event reported):  July 7, 2003



                      HEMACARE CORPORATION
     (Exact Name of Registrant as Specified in its Charter)



                           CALIFORNIA
         (State or other jurisdiction of incorporation)



      000-15223                          95-3280412
(Commission File No.)         (IRS Employer Identification No.)



                       21101 Oxnard Street
                    Woodland Hills, CA 91367
      (Address of principal executive offices and Zip Code)



Registrant's telephone number, including area code: (818) 226-1968

                              -1-



ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE

The text of a press release dated July 8, 2003, issued by
HemaCare Corporation ("HemaCare") annoucing that it has
reopened its search for a Chief Financial Officer is attached as
Exhibit 99.1 hereto and is incorporated by reference herein.


ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

(c) Exhibits

Exhibit Number   Description

99.1             Press Release issued by HemaCare, dated
                 July 8, 2003


                           SIGNATURES

Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the registrant has duly caused this report to be signed  on
its behalf by the undersigned hereunto duly authorized.



Date: July 7, 2003           HEMACARE CORPORATION

                             /s/ Judi Irving
                             ----------------------------
                              Judi Irving,
                              Chief Executive Officer




                          EXHIBIT INDEX

Exhibit Number   Description
- --------------   -----------
99.1             Press Release issued by HemaCare, dated July
                 8, 2003


                                 -2-